185 related articles for article (PubMed ID: 12399106)
1. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
Thakker DR; Standifer KM
Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
[TBL] [Abstract][Full Text] [Related]
2. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
3. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
Mandyam CD; Thakker DR; Standifer KM
J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
[TBL] [Abstract][Full Text] [Related]
5. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
6. Expression of opioid receptor-like 1 (ORL1) & mu opioid receptors in the spinal cord of morphine tolerant mice.
Ray SB; Gupta YK; Wadhwa S
Indian J Med Res; 2005 Mar; 121(3):194-202. PubMed ID: 15802762
[TBL] [Abstract][Full Text] [Related]
7. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
Olianas MC; Dedoni S; Boi M; Onali P
J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
9. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
[TBL] [Abstract][Full Text] [Related]
10. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
Grisel JE; Farrier DE; Wilson SG; Mogil JS
Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
[TBL] [Abstract][Full Text] [Related]
12. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
Ozsoy HZ; Thakker DR; Standifer KM
Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
[TBL] [Abstract][Full Text] [Related]
13. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells.
Mathis JP; Mandyam CD; Altememi GF; Pasternak GW; Standifer KM
Neurosci Lett; 2001 Feb; 299(3):173-6. PubMed ID: 11165763
[TBL] [Abstract][Full Text] [Related]
14. Functional blockade of opioid analgesia by orphanin FQ/nociceptin.
King M; Chang A; Pasternak GW
Biochem Pharmacol; 1998 May; 55(9):1537-40. PubMed ID: 10076548
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
18. Functional studies using antibodies against orphanin FQ/nociceptin.
Tian JH; Han JS
Peptides; 2000 Jul; 21(7):1047-50. PubMed ID: 10998539
[TBL] [Abstract][Full Text] [Related]
19. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
Kotlińska J; Rafalski P
Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
